Armata Pharmaceuticals Inc.
ARMP | AMEX
$4.26
+$0.08 (+1.91%)
At close: Sep 21, 2026, 4:00 PM ET
$4.15
-$0.11 (-2.58%)
Pre-market:
Sep 22, 2026, 5:22 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 4.9M | 5.17M | 4.53M | 5.51M | 4.47M | 823K |
Cost of Revenue | 1.53M | 34.43M | 972K | 35.02M | 20.02M | 14.44M |
Gross Profit | 3.37M | -29.25M | 3.56M | -29.51M | -15.54M | -13.62M |
Operating Income | -31.22M | -42.44M | -40.89M | -36.95M | -23.82M | -21.59M |
Interest Income | 388K | 697K | 179K | 29K | 5K | 28K |
Pretax Income | -173.8M | -18.92M | -69.05M | -36.92M | -23.16M | -22.18M |
Net Income | -173.8M | -18.92M | -69.05M | -36.92M | -23.16M | -22.18M |
Selling & General & Admin | 12.41M | 13.18M | 10.68M | 7.44M | 8.28M | 7.97M |
Research & Development | 23.72M | 34.43M | 33.77M | 35.02M | 20.02M | 14.44M |
Other Expenses | -1.53M | -34.43M | n/a | -35.02M | -20.02M | -14.44M |
Operating Expenses | 34.6M | 13.18M | 44.45M | 7.44M | 8.28M | 7.97M |
Interest Expense | 16.59M | 10.74M | 2.63M | 29K | 64K | 628K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 36.13M | 47.61M | 45.42M | 42.45M | 28.3M | 22.41M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 36.24M | 36.16M | 36.08M | 34.29M | 24.1M | 16.42M |
Shares Outstanding (Diluted) | 36.24M | 36.16M | 36.08M | 34.29M | 24.1M | 16.42M |
EPS (Basic) | -4.80 | -0.52 | -1.91 | -1.08 | -0.96 | -1.35 |
EPS (Diluted) | -4.80 | -0.52 | -1.91 | -1.08 | -0.96 | -1.35 |
EBITDA | -155.68M | -6.85M | -65.45M | -36M | -21.92M | -20.44M |
EBIT | -157.21M | -8.17M | -66.42M | -36.89M | -23.09M | -21.55M |
Depreciation & Amortization | 1.53M | 1.33M | 972K | 892K | 1.17M | 1.11M |
Add to Watchlist
Select watchlists to add or remove ARMP